Last reviewed · How we verify
StrataMGT
At a glance
| Generic name | StrataMGT |
|---|---|
| Sponsor | Andrew T. Goldstein, MD |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- VALOR: Vaginal Atrophy & Long-term Observation of Recovery (NA)
- Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause (NA)
- StrataMGT for the Treatment of Vulvar Lichen Sclerosus (NA)
- StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- StrataMGT CI brief — competitive landscape report
- StrataMGT updates RSS · CI watch RSS
- Andrew T. Goldstein, MD portfolio CI